Navigation Links
PDL BioPharma Announces Third Quarter 2011 Financial Results
Date:11/9/2011

and uncertainties. Actual results may differ materially from those, express or implied, in these forward-looking statements. Factors that may cause differences between current expectations and actual results include, but are not limited to, the following:

  • The expected rate of growth in royalty-bearing product sales by PDL's existing licensees;
  • The relative mix of royalty-bearing Genentech products manufactured and sold outside the U.S. versus manufactured or sold in the U.S.;
  • The ability of PDL's licensees to receive regulatory approvals to market and launch new royalty-bearing products and whether such products, if launched, will be commercially successful;
  • Changes in any of the other assumptions on which PDL's projected royalty revenues are based;
  • The outcome of pending litigation or disputes;
  • The change in foreign currency exchange rates; and
  • The failure of licensees to comply with existing license agreements, including any failure to pay royalties due.

  • Other factors that may cause PDL's actual results to differ materially from those expressed or implied in the forward-looking statements in this press release are discussed in PDL's filings with the SEC, including the "Risk Factors" section of its annual and quarterly reports filed with the SEC. Copies of PDL's filings with the SEC may be obtained at the "Investors" section of PDL's website at www.pdl.com. PDL expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in PDL's expectations with regard thereto or any change in events, conditions or circumstances on which any such statements are based for any reason, except as required by law, even as new information becomes available or other events occur in the future. All forward-looking statements in this press release are qualified in their entirety b
    '/>"/>

    SOURCE PDL BioPharma, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11

    Related medicine technology :

    1. Planet Biopharmaceuticals, Inc. Divests Assets of Allergy Control Products, Inc.
    2. Keryx Biopharmaceuticals, Inc. Announces Third Quarter 2011 Financial Results
    3. PDL BioPharma to Announce Third Quarter 2011 Financial Results on November 9, 2011
    4. Keryx Biopharmaceuticals, Inc. to Host Conference Call on Third Quarter 2011 Financial Results
    5. PAREXEL Expands Commercialization Capabilities With Dedicated Team to Help Biopharma Companies Demonstrate Product Value
    6. Sentry BioPharma Services Earns a GSA Federal Supply Schedule Contract #GS-10F-0432X
    7. Genesis Biopharma Signs Worldwide License Agreement with the NIH for Adoptive Cell Therapy to Treat a Variety of Cancers
    8. Inspiration Biopharmaceuticals Names John P. Butler Chief Executive Officer
    9. CoLucid Pharmaceuticals to Present at Sofinnova Japan Biopharma Partnering Conference on Tuesday, October 4th in Tokyo, Japan
    10. Experts to Provide Successful Strategies for Global Biopharmaceutical Development and Commercialization at PAREXEL Tokyo Seminar
    11. Regado Biosciences, Inc. to Present at the Sofinnova Japan Biopharma Partnering Conference in Tokyo, Japan
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:1/23/2015)... More than a third of reproductive-aged women enrolled in Medicaid, ... filled a prescription for an opioid pain medication each year ... and Mortality Weekly Report (MMWR). Opioids are ... severe pain.  They are also found in some prescription cough ...
    (Date:1/23/2015)... YORK , Jan. 23, 2015 /PRNewswire/-- Harwood Feffer LLP ... board of directors of Advaxis, Inc. ("Advaxis" or the ... board has breached its fiduciary duties to shareholders. ... on an investing website reporting that Advaxis had misrepresented ...
    (Date:1/23/2015)... GAINESVILLE, Fla. , Jan. 23, 2015  HyGreen, Inc., ... distribution agreement and partnership with RCA Medical, a subsidiary ... Africa . Each year, hundreds of ... health care-associated infections as organisms are transmitted from patient ...
    Breaking Medicine Technology:Opioid painkillers widely prescribed among reproductive age women 2Opioid painkillers widely prescribed among reproductive age women 3Harwood Feffer LLP Announces Investigation of Advaxis, Inc. 2HyGreen Partners with RCA Medical in Johannesburg, South Africa 2
    ... SAN DIEGO , Feb. 5 Volcano Corporation (Nasdaq: ... filed by Lightlab Imaging, Inc. on January 7, 2009 ... reached a verdict against Volcano and its wholly owned subsidiary, ... had an agreement to supply tunable lasers to Lightlab for use ...
    ... Feb. 4 PSKW & Associates LLC ... Card, has purchased Triax Media LLC of Irvine, California . ... subsidiary, Centricity Group LLC of Mendham, New Jersey . , ... physician and patient communications. The purchase of Triax Media complements those ...
    Cached Medicine Technology:Volcano Corporation Announces Litigation Status 2Volcano Corporation Announces Litigation Status 3PSKW & Associates LLC Acquires Triax Media, Licenses Triax to Subsidiary, Centricity Group 2
    (Date:1/22/2015)... January 22, 2015 Deer Path of Huntley ... a Valentine’s Day Happy Hour from 3 p.m. to 4 p.m. ... Regency Parkway in Huntley, Illinois, serves adults with physical disabilities between ... will include Valentine's Day treats, games and sweetheart-themed karaoke. , For ...
    (Date:1/22/2015)... The City of West Hollywood hosted a news conference ... 42nd anniversary of the Supreme Court decision Roe v. Wade, which ... since the Roe vs. Wade decision and the fight to protect ... said City of West Hollywood Councilmember Abbe Land. “We need to ...
    (Date:1/22/2015)... 23, 2015 VogueQueen is a seasoned and ... and many designers are thrilled to have it lead the ... its new collection of prom dresses for the global market. ... the strategic vision and he focuses on continuing the goal ...
    (Date:1/22/2015)... (PRWEB) January 23, 2015 AngelWeddingDress, the ... of 2015 maternity wedding dresses. View website ... are looking for maternity wedding dresses online for a ... gowns with high quality for them. Its maternity wedding ...
    (Date:1/22/2015)... New York (PRWEB) January 22, 2015 ... after Fresenius Medical Care recalled its GranuFlo and NaturaLyte ... multidistrict litigation underway in U.S. District Court, District of ... dated January 20th, the Court has remanded a case ...
    Breaking Medicine News(10 mins):Health News:Deer Path of Huntley Affordable Assisted Living to Host Valentine's Day Happy Hour 2Health News:VogueQueen Unveils New Designs of Prom Dresses for 2015 2Health News:AngelWeddingDress Has Recently Released Its Collection Of 2015 Maternity Wedding Dresses 2Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 2Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 3Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 4
    ... provides important insights on the use of ... practice -, AMSTERDAM, The Netherlands, Dec. 14 ... prognosis test was,successfully implemented in the diagnostic process ... Netherlands. MammaPrint(R) assigned,up to one- third of the ...
    ... UC Riversides Douglas Ethell , an assistant ... die in disorders such as Alzheimers and Parkinsons, has ... Institute for Regenerative Medicine ( CIRM ), Californias stem ... Faculty Award by CIRM, will fund Ethells research on ...
    ... to traffic pollution may increase respiratory problems and reduce ... who studied the effects of road and traffic density ... border town of Ciudad Juarez in Mexico. , Our ... either at home or at school, can lead to ...
    ... Dec. 13 The Ensign,Group, Inc. (Nasdaq: ... group of,skilled nursing, rehabilitative care services and assisted ... of two skilled,nursing facilities in California and one ... price of approximately $12.8 million., (Logo: ...
    ... practices can put as much strain on a womans ... year, an extensive study of the British workforce funded ... , The research finds that while British employers have ... competitive market pressures, they have devised ways of extracting ...
    ... Inc. (Nasdaq: ADLS ), a biopharmaceutical company ... drugs in the,therapeutic areas of infection, cancer and ... of approximately 10.2 million,shares of common stock together ... common stock to a group of new and ...
    Cached Medicine News:Health News:Study Shows MammaPrint(R) Breast Cancer Test Provides Benefits to Patients from Personalized Treatment Regimen 2Health News:Study Shows MammaPrint(R) Breast Cancer Test Provides Benefits to Patients from Personalized Treatment Regimen 3Health News:UCR researcher awarded $2.1M stem cell grant to study Alzheimer's disease 2Health News:UCR researcher awarded $2.1M stem cell grant to study Alzheimer's disease 3Health News:Heavy traffic makes breathing a burden in children 2Health News:The Ensign Group, Inc. Acquires Assets of Three Previously Leased Facilities 2Health News:Workplace opportunities and stresses are both increasing 2Health News:Workplace opportunities and stresses are both increasing 3Health News:Workplace opportunities and stresses are both increasing 4Health News:Advanced Life Sciences Completes Private Placement for $20 Million 2Health News:Advanced Life Sciences Completes Private Placement for $20 Million 3
    ... The Deluxe specimen bath mounts inside the ... bath allows for the separation of buffer and ... The bath can be sterilized and has round ... mounting specimens. The disks and bath surface ...
    ... A simple device designed to mount ... This product facilitates the mounting of all ... It is especially useful for mounting tissue ... as those produced with a Vibratome, freezing ...
    Punch set for Advanced Tissue Arrayer, 0.6 mm...
    Inquire...
    Medicine Products: